Diagnosis Glaucoma is a podcast for people with glaucoma, or for anyone simply interested in learning more about the eye condition. The hosts, Dr. Kaleem and Dr. Quigley, are both experts in glaucoma who work together at the Wilmer Eye Institute at Johns Hopkins University, which is among the leading eye hospitals in the world. They created this educational resource for patients in order to explain the ins and outs of glaucoma in an easy to understand language that even those who do not have a medical background can comprehend. Together, they break down the answers to some commonly asked questions and also discuss the latest news in glaucoma that you should know about.
Mona Kaleem, MD
Mona Kaleem, MD is an Associate Professor of Ophthalmology at the Johns Hopkins University School of Medicine’s Wilmer Eye Institute. She specializes in glaucoma and cataract surgery. In addition to running a busy clinical and surgical service, she is also a dedicated researcher, educator, and volunteer. Dr. Kaleem is best known for her interest in improving quality of life for glaucoma patients. She currently holds research grants from the American Glaucoma Society and the Abell Foundation. She has published numerous peer reviewed articles and book chapters.
Harry Quigley, MD
Harry Quigley, MD is the A. Edward Maumenee Professor of Ophthalmology at the Johns Hopkins University School of Medicine’s Wilmer Eye Institute. He is a founding member of the American Glaucoma Society. His research interests include causes of vision loss in glaucoma, new imaging technology in the diagnosis of angle closure glaucoma, neuroprotective treatments for glaucoma, evaluation of surgical operations for glaucoma, research into solutions to glaucoma treatment worldwide. Dr. Quigley has also authored “Glaucoma: What Every Patient Should Know,” a patient-centered guide to all things glaucoma.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
Thank you for driving glaucoma research forward! We are so grateful for your support.